Cell-penetrating peptides as delivery vehicles for biology and medicine.

Cell-penetrating peptides (CPPs) have found numerous applications in biology and medicine since the first synthetic cell-permeable sequence was identified two decades ago. Numerous types of drugs have been transported into cells using CPPs, including small-molecule pharmaceuticals, therapeutic proteins, and antisense oligonucleotides. Improved agents for medical imaging have been generated by conjugation with CPPs, with the appended peptides promoting cellular uptake and in some cases, cell-type specificity. Organelle-specific CPPs have also been generated, providing a means to target specific subcellular sites. This review highlights achievements in this area and illustrates the numerous examples where peptide chemistry was exploited as a means to provide new tools for biology and medicine.

[1]  Roger D. Kornberg,et al.  Synthetic peptides as nuclear localization signals , 1986, Nature.

[2]  T J Brady,et al.  Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. , 1987, Radiology.

[3]  Maurice Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein , 1988, Cell.

[4]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[5]  R. Liskamp,et al.  Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C. , 1990, Cellular immunology.

[6]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[8]  London Wc,et al.  De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity , 1996 .

[9]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[10]  A. Alivisatos.  Semiconductor Clusters, Nanocrystals, and Quantum Dots , 1996, Science.

[11]  T. Szekeres,et al.  Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells. , 1996, Biochemical pharmacology.

[12]  P. Collas,et al.  Nuclear localization signals: a driving force for nuclear transport of plasmid DNA in zebrafish. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[13]  B. Groner,et al.  Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.

[14]  M. Barkley,et al.  Self-assembly of designed antimicrobial peptides in solution and micelles. , 1997, Biochemistry.

[15]  K Svanberg,et al.  In vivo fluorescence imaging for tissue diagnostics. , 1997, Physics in medicine and biology.

[16]  F. Szoka,et al.  Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. , 1998, Biochimica et biophysica acta.

[17]  J. Gariépy,et al.  Penetration and intracellular routing of nucleus-directed peptide-based shuttles (loligomers) in eukaryotic cells. , 1998, Biochemistry.

[18]  R. Gennaro,et al.  Cytotoxicity and apoptosis mediated by two peptides of innate immunity. , 1998, Cellular immunology.

[19]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  R. Jain.  The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.

[21]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[22]  B. Deurs,et al.  Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. , 1999, Molecular biology of the cell.

[23]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[24]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[25]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[26]  Scott L. Diamond,et al.  Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells , 1999, Nature Biotechnology.

[27]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Zhang,et al.  A transfecting peptide derived from adenovirus fiber protein , 1999, Gene Therapy.

[29]  R. Lutz,et al.  Bak BH3 Peptides Antagonize Bcl-xL Function and Induce Apoptosis through Cytochrome c-independent Activation of Caspases* , 1999, The Journal of Biological Chemistry.

[30]  L. Chaloin,et al.  A novel potent strategy for gene delivery using a single peptide vector as a carrier. , 1999, Nucleic acids research.

[31]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[32]  A. Lobuglio,et al.  Induction of anti‐tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine , 2000, The journal of gene medicine.

[33]  K. Gelmon,et al.  In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. , 2000, Anti-cancer drug design.

[34]  C. Christophe-Hobertus,et al.  Nuclear targeting of proteins: how many different signals? , 2000, Cellular signalling.

[35]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[36]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[37]  J. Rothbard,et al.  Polyarginine enters cells more efficiently than other polycationic homopolymers. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[38]  J. Rothbard,et al.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.

[39]  R Weissleder,et al.  Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. , 2000, Bioconjugate chemistry.

[40]  S. Sarkar,et al.  Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery. , 2000, Cardiovascular research.

[41]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[42]  Robin A. J. Smith,et al.  Drug delivery to mitochondria: the key to mitochondrial medicine. , 2000, Advanced drug delivery reviews.

[43]  B. Nordén,et al.  The Antennapedia peptide penetratin translocates across lipid bilayers – the first direct observation , 2000, FEBS letters.

[44]  E. Alnemri,et al.  Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. , 2000, Cancer research.

[45]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[46]  C. Rousselle,et al.  Doxorubicin-peptide conjugates overcome multidrug resistance , 2001, Anti-cancer drugs.

[47]  J. Mai,et al.  A proapoptotic peptide for the treatment of solid tumors. , 2001, Cancer research.

[48]  S. Futaki,et al.  Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.

[49]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[51]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[52]  G. Dorn,et al.  Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Inokuchi,et al.  Enhancement of phage-mediated gene transfer by nuclear localization signal. , 2002, Biochemical and biophysical research communications.

[54]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[55]  Ralph Weissleder,et al.  Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. , 2002, Bioconjugate chemistry.

[56]  Michael Weller,et al.  Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.

[57]  G. Kroemer,et al.  Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL , 2002, Oncogene.

[58]  S. Goueli,et al.  Selective in Vivo Inhibition of Mitogen-activated Protein Kinase Activation Using Cell-permeable Peptides* 210 , 2002, The Journal of Biological Chemistry.

[59]  J. Debus,et al.  CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm. , 2002, Cancer research.

[60]  C. Stein,et al.  Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells. , 2002, Bioconjugate chemistry.

[61]  S. Ohta,et al.  Protection against ischemic brain injury by protein therapeutics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Cartier,et al.  Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.

[63]  Ralph Weissleder,et al.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.

[64]  Paolo Bernardi,et al.  BMAP-28, an Antibiotic Peptide of Innate Immunity, Induces Cell Death through Opening of the Mitochondrial Permeability Transition Pore , 2002, Molecular and Cellular Biology.

[65]  D. Seebach,et al.  Cellular Uptake Studies with β‐Peptides , 2002 .

[66]  M. Giacca,et al.  Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins* , 2003, Journal of Biological Chemistry.

[67]  R. Weissleder,et al.  Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. , 2003, Bioconjugate chemistry.

[68]  J. Debus,et al.  Intracellular visualization of prostate cancer using magnetic resonance imaging. , 2003, Cancer research.

[69]  S. Franzen,et al.  Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. , 2003, Journal of the American Chemical Society.

[70]  Niv Papo,et al.  New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. , 2003, Biochemistry.

[71]  Thomas J. Meade,et al.  Synthesis and visualization of a membrane-permeable MRI contrast agent , 2003, JBIC Journal of Biological Inorganic Chemistry.

[72]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[73]  A. Phelan,et al.  Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  Eric Vives,et al.  Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.

[75]  S. Gellman,et al.  Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a β-Peptide after Endocytic Uptake into HeLa Cells* , 2003, Journal of Biological Chemistry.

[76]  Jindrich Kopecek,et al.  Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.

[77]  Michael G. Yang,et al.  Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable taxol-transporter conjugates. , 2003, Organic letters.

[78]  S. Matile,et al.  Anion-mediated transfer of polyarginine across liquid and bilayer membranes. , 2003, Journal of the American Chemical Society.

[79]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[80]  L. Roudaia,et al.  Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. , 2003, Biochemistry.

[81]  Changhee Min,et al.  Dendritic oligoguanidines as intracellular translocators. , 2004, Biopolymers.

[82]  M. Brand,et al.  Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. , 2004, Diabetes.

[83]  Steven F. Dowdy,et al.  Cell Penetrating Peptides in Drug Delivery , 2004, Pharmaceutical Research.

[84]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[85]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[86]  R. L. Juliano,et al.  Conjugates of Antisense Oligonucleotides with the Tat and Antennapedia Cell-Penetrating Peptides: Effects on Cellular Uptake, Binding to Target Sequences, and Biologic Actions , 2004, Pharmaceutical Research.

[87]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[88]  C. Leuschner,et al.  Membrane disrupting lytic peptides for cancer treatments. , 2004, Current pharmaceutical design.

[89]  A. Gabizon,et al.  Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues. , 2004, Bioconjugate chemistry.

[90]  M. Eccles,et al.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.

[91]  D. Ly,et al.  Multicolor Coding of Cells with Cationic Peptide Coated Quantum Dots , 2004 .

[92]  Bernd Groner,et al.  The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. , 2004, Molecular cancer research : MCR.

[93]  A. Prochiantz,et al.  Transduction peptides: from technology to physiology , 2004, Nature Cell Biology.

[94]  Yaming Su,et al.  Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells. , 2004, Molecular pharmaceutics.

[95]  W. El-Deiry,et al.  Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: An effective multi-faceted targeting of the tumor-cell phenotype? , 2004, Cancer biology & therapy.

[96]  R. Raines,et al.  Pathway for polyarginine entry into mammalian cells. , 2004, Biochemistry.

[97]  Weihong Tan,et al.  TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. , 2004, Chemical communications.

[98]  J. Chmielewski,et al.  Probing essential residues for cellular uptake with a cationic nuclear localization signal sequence. , 2008, The journal of peptide research : official journal of the American Peptide Society.

[99]  D. Alonso,et al.  Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2) , 2004, Cancer Research.

[100]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[101]  H. Szeto,et al.  Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury* , 2004, Journal of Biological Chemistry.

[102]  G. Courtois,et al.  Inhibition of NF-κB Activation by Peptides Targeting NF-κB Essential Modulator (NEMO) Oligomerization* , 2004, Journal of Biological Chemistry.

[103]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[104]  A. Prochiantz,et al.  Membrane interaction and cellular internalization of penetratin peptides. , 2004, European journal of biochemistry.

[105]  Y. Jiang,et al.  Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide , 2004, Gene Therapy.

[106]  Ralph Weissleder,et al.  Intracellular cargo delivery using tat peptide and derivatives , 2004, Medicinal research reviews.

[107]  T. Rana,et al.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.

[108]  T. Meade,et al.  Cellular delivery of MRI contrast agents. , 2004, Chemistry & biology.

[109]  R. Fischer,et al.  Break on through to the Other Side—Biophysics and Cell Biology Shed Light on Cell‐Penetrating Peptides , 2005, Chembiochem : a European journal of chemical biology.

[110]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[111]  Glenn Walter,et al.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.

[112]  S. Futaki,et al.  Arginine magic with new counterions up the sleeve. , 2005, Organic & biomolecular chemistry.

[113]  J. Rothbard,et al.  Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. , 2005, Advanced drug delivery reviews.

[114]  D. Seebach,et al.  Bacterial Cell Penetration by β3‐Oligohomoarginines: Indications for Passive Transfer through the Lipid Bilayer , 2005, Chembiochem : a European journal of chemical biology.

[115]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[116]  P. Collas,et al.  The nuclear localization sequence of the SV40 T antigen promotes transgene uptake and expression in zebrafish embryo nuclei , 1996, Transgenic Research.

[117]  E. Snyder,et al.  Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides. , 2005, Cancer research.

[118]  S. Gellman,et al.  Effects of side chain configuration and backbone spacing on the gene delivery properties of lysine-derived cationic polymers. , 2005, Bioconjugate chemistry.

[119]  V. Yang,et al.  Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. , 2005, Bioorganic & medicinal chemistry letters.

[120]  Vladimir P Torchilin,et al.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. , 2005, Advanced drug delivery reviews.

[121]  S. Gellman,et al.  Effects of conformational stability and geometry of guanidinium display on cell entry by beta-peptides. , 2005, Journal of the American Chemical Society.

[122]  Steven F Dowdy,et al.  Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. , 2005, Advanced drug delivery reviews.

[123]  F. Hudecz,et al.  Medium‐sized peptides as built in carriers for biologically active compounds , 2005, Medicinal research reviews.

[124]  S. Futaki,et al.  Direct Observation of Anion‐Mediated Translocation of Fluorescent Oligoarginine Carriers into and across Bulk Liquid and Anionic Bilayer Membranes , 2005, Chembiochem : a European journal of chemical biology.

[125]  Shiroh Futaki,et al.  Anionic fullerenes, calixarenes, coronenes, and pyrenes as activators of oligo/polyarginines in model membranes and live cells. , 2005, Journal of the American Chemical Society.

[126]  E. Giralt,et al.  Cell-Penetrating cis-γ-Amino-l-Proline-Derived Peptides , 2005 .

[127]  H. Merkle,et al.  Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. , 2005, Biophysical journal.

[128]  W. Ou,et al.  Photoactivation of quantum dot fluorescence following endocytosis. , 2005, Nano letters.

[129]  G. Colombo,et al.  Rational design of shepherdin, a novel anticancer agent. , 2005, Cancer cell.

[130]  Miguel A R B Castanho,et al.  Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. , 2005, Biochemistry.

[131]  Y. Okahata,et al.  Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[132]  Rajesh R Naik,et al.  Cellular internalization and targeting of semiconductor quantum dots. , 2005, Chemical communications.

[133]  B. Lebleu,et al.  Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.

[134]  P. Brandt-Rauf,et al.  Selective induction of apoptosis through the FADD/caspase‐8 pathway by a p53 c‐terminal peptide in human pre‐malignant and malignant cells , 2005, International journal of cancer.

[135]  P. Pohl,et al.  A critical reassessment of penetratin translocation across lipid membranes. , 2005, Biophysical journal.

[136]  J. Seelig,et al.  The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. , 2005, Biochemistry.

[137]  Ralph Weissleder,et al.  Protamine as an efficient membrane-translocating peptide. , 2005, Bioconjugate chemistry.

[138]  Leroy Cronin,et al.  Quantum Dots Protected with Tiopronin: A New Fluorescence System for Cell‐Biology Studies , 2005, Chembiochem : a European journal of chemical biology.

[139]  M. Morris,et al.  Cell-penetrating peptides: tools for intracellular delivery of therapeutics , 2005, Cellular and Molecular Life Sciences CMLS.

[140]  M. Ferrer,et al.  Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.

[141]  B. Lebleu,et al.  Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides. , 2006, Biochemistry.

[142]  P. Iversen,et al.  Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[143]  Min Liu,et al.  Application of cell penetrating peptide in magnetic resonance imaging of bone marrow mesenchymal stem cells. , 2006, Acta biochimica et biophysica Sinica.

[144]  R. Weissleder,et al.  A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity , 2006, Molecular Cancer Therapeutics.

[145]  M. Ronjat,et al.  Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. , 2006, Biochimica et biophysica acta.

[146]  J. Bruce,et al.  Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide , 2006, Molecular Cancer Therapeutics.

[147]  D. Seebach,et al.  Interaction of α-and β-Oligoarginine-Acids and Amides with Anionic Lipid Vesicles: A Mechanistic and Thermodynamic Study† , 2006 .

[148]  S. Futaki,et al.  Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate. , 2006, ACS chemical biology.

[149]  L. Galluzzi,et al.  Mitochondria as therapeutic targets for cancer chemotherapy , 2006, Oncogene.

[150]  T. Restle,et al.  Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect , 2006, Nucleic acids research.

[151]  Ű. Langel,et al.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.

[152]  A. Clayton,et al.  Conformation and orientation of penetratin in phospholipid membranes , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[153]  Carol S. Lim,et al.  Controlling Protein Compartmentalization to Overcome Disease , 2006, Pharmaceutical Research.

[154]  S. Futaki,et al.  Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[155]  D. Hoskin,et al.  Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment , 2006, Expert opinion on investigational drugs.

[156]  E. Novellino,et al.  A Membrane-Permeable Peptide Containing the Last 21 Residues of the GαS Carboxyl Terminus Inhibits GS-Coupled Receptor Signaling in Intact Cells: Correlations between Peptide Structure and Biological Activity , 2006, Molecular Pharmacology.

[157]  Christoph Patsch,et al.  The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .

[158]  Igor L. Medintz,et al.  Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. , 2006, Bioconjugate chemistry.

[159]  J. Rothbard,et al.  Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real‐Time Imaging , 2006, Chembiochem : a European journal of chemical biology.

[160]  R. Reilly,et al.  HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. , 2006, Bioconjugate chemistry.

[161]  Miguel A R B Castanho,et al.  Cell-penetrating peptides and antimicrobial peptides: how different are they? , 2006, The Biochemical journal.

[162]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[163]  S. Futaki,et al.  Effects of cell-permeating peptide binding on the distribution of 125I-labeled Fab fragment in rats. , 2006, Bioconjugate chemistry.

[164]  A. Melnick,et al.  Specific peptides for the therapeutic targeting of oncogenes. , 2006, Current opinion in genetics & development.

[165]  Min Liu,et al.  Paramagnetic particles carried by cell-penetrating peptide tracking of bone marrow mesenchymal stem cells, a research in vitro. , 2006, Biochemical and biophysical research communications.

[166]  A. MacRobert,et al.  Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid. , 2007, Bioorganic & medicinal chemistry letters.

[167]  P. Rustin,et al.  Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of αVβ3-expressing endothelial cells , 2007, Cell Death and Differentiation.

[168]  G. Forloni,et al.  JNK signalling: a possible target to prevent neurodegeneration. , 2007, Current pharmaceutical design.

[169]  B. Lebleu,et al.  Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide , 2007, Nucleic acids research.

[170]  Ű. Langel,et al.  Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. , 2007, Biophysical journal.

[171]  G. Poon.  Enhancement of oligomeric stability by covalent linkage and its application to the human p53tet domain: thermodynamics and biological implications. , 2007, Biochemical Society transactions.

[172]  Ü. Langel,et al.  A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[173]  S. Gellman,et al.  HeLa Cell Entry by Guanidinium‐Rich β‐Peptides: Importance of Specific Cation–Cell Surface Interactions , 2007, Chembiochem : a European journal of chemical biology.

[174]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[175]  Dominic J. Glover,et al.  Histone-mediated transduction as an efficient means for gene delivery. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[176]  E. Pérez-Payá,et al.  Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: Effective methods to improve inhibition of mitochondria-mediated apoptosis , 2007, Peptides.

[177]  D. Krag,et al.  Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells , 2007, British Journal of Cancer.

[178]  Rainer Fischer,et al.  A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.

[179]  J. Gariépy,et al.  Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. , 2007, Biochemical Society transactions.

[180]  Steven F Dowdy,et al.  Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. , 2007, Advanced drug delivery reviews.

[181]  A. Waring,et al.  Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. , 2007, Journal of the American Chemical Society.

[182]  B. Cornelissen,et al.  Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells. , 2007, Nuclear medicine and biology.

[183]  T. Tarragó,et al.  all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study. , 2007, Biochemical Society transactions.

[184]  Arwyn Tomos Jones,et al.  Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides , 2007, Journal of cellular and molecular medicine.

[185]  Ü. Langel,et al.  Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  A. Barron,et al.  The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes. , 2007, Organic & biomolecular chemistry.

[187]  K. Uğurbil,et al.  Synthesis and cellular uptake of a MR contrast agent coupled to an antisense peptide nucleic acid--cell- penetrating peptide conjugate. , 2007, Contrast media & molecular imaging.

[188]  Ű. Langel,et al.  Applications of cell-penetrating peptides in regulation of gene expression. , 2007, Biochemical Society transactions.

[189]  J. Rao,et al.  Fluorescence imaging in vivo: recent advances. , 2007, Current opinion in biotechnology.

[190]  Vladimir Petrovic,et al.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. , 2007, The Journal of clinical investigation.

[191]  S. Futaki,et al.  Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. , 2007, Biochemistry.

[192]  M. Lindsay,et al.  Cell-penetrating-peptide-mediated siRNA lung delivery. , 2007, Biochemical Society transactions.

[193]  T. Chiles,et al.  Deconvolution of the cellular oxidative stress response with organelle-specific Peptide conjugates. , 2007, Chemistry & biology.

[194]  M. Rezaee,et al.  Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. , 2007, Cardiovascular research.

[195]  Tatsushi Toda,et al.  Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[196]  Simon W. Jones,et al.  Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. , 2007, Bioconjugate chemistry.

[197]  Byung-Soo Kim,et al.  Poly(l-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA , 2007, Journal of drug targeting.

[198]  Steven F Dowdy,et al.  Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. , 2008, Advanced drug delivery reviews.

[199]  S. Kelley,et al.  Mitochondria-penetrating peptides. , 2008, Chemistry & biology.

[200]  T. Wagner,et al.  In vivo targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two γ-linked glutamate residues at the COOH terminus. , 2001, Molecular medicine reports.